Study of Birth Control Use After Childbirth

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

800 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-05-31

Study Completion Date

2012-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a randomized controlled trial that will evaluate the impact of a brief educational script on the method of birth control that women receive at their 6-week postpartum visit. The one-minute script ("LARC script") is given to women in the hospital during their postpartum admission. It informs patients about long-acting reversible contraceptive (LARC) methods, specifically the contraceptive implant and the intrauterine device. The investigators hypothesize that women who are randomized to receive the LARC script will be more likely to report that they are using a LARC method, when queried immediately after their six-week postpartum visit.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

LNG-IUS at 2 Weeks Postpartum

NCT02121067

Contraception Malposition of Intrauterine Contraceptive Device

COMPLETED PHASE4

Contraceptive Counseling in the Postpartum Period

NCT02380781

Postpartum Contraceptive Counseling

COMPLETED NA

Patient Compliance With Long-Acting Reversible Contraception Administration

NCT03305081

Contraception

TERMINATED NA

Adolescent Postpartum Contraceptive Counseling Intervention

NCT01814930

Adolescent Pregnancy

COMPLETED NA

Postpartum Etonogestrel Implant for Adolescents

NCT01666912

Adolescence Contraception Postpartum

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contraception

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LARC script

Received routine postpartum counseling and LARC script.

Group Type EXPERIMENTAL

LARC Script

Intervention Type BEHAVIORAL

The LARC Script is a one-minute educational script that describes long-acting reversible contraceptive methods.

No LARC script

Received only routine postpartum counseling

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LARC Script

The LARC Script is a one-minute educational script that describes long-acting reversible contraceptive methods.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women who are admitted to the postpartum unit at WakeMed Hospital
* Delivery of a live infant \>24 weeks gestational age
* Age 14-45 years
* Ability to speak either English or Spanish fluently
* Willing to be contacted by phone until at least 8 weeks after delivery

Exclusion Criteria

* History of a tubal ligation or hysterectomy
* Partner has already had a vasectomy
* History of fertility treatment to conceive this pregnancy
* Previous randomization into the study

Minimum Eligible Age

14 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes